相关实验视频

Updated: Jan 11, 2026

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

来自Ohwia caudata茎的生物活性黄类药物会影响小肠移动性ex vivo

Jingya Ruan¹, Dingshan Yang¹, Qianqian Geng¹

¹State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New Town, Jinghai District, 301617, Tianjin, China.

Bioorganic chemistry

|November 15, 2025

概括

奥威亚尾状显示出治疗腹占主导地位的刺激性肠综合征 (IBS-D) 的治疗潜力. 它的黄胺通过通道阻塞和氧化合成酶激活来抑制肠道收缩,为IBS-D药物开发提供了新的途径.

科学领域:

植物化学植物化学
药理学药理学是指药理学的学科.
胃肠病学胃肠病学

背景情况:

刺激性肠综合征与腹 (IBS-D) 是一种普遍的胃肠道疾病.
传统的草药为IBS-D管理提供了潜在的治疗途径.
黄是一种植物,在治疗胃肠道疾病方面有着悠久的历史.

研究的目的:

为了研究Ohwia caudata对IBS-D的治疗潜力.
为了识别和描述O.caudata.的活性黄化合物成分.
阐明这些黄类药物的抗腹作用背后的多模式机制.

主要方法:

植物化学分析以确定O.caudata提取物中的黄类.
在体外测试以评估分离化合物对肠道平滑肌肉收缩的影响.
机制研究以确定参与观察到的药理活动的途径.
结构-活动关系分析以确定有效性的关键结构特征.

主要成果:

在O.caudata中发现了40种黄类化合物,其中12种是新报告的.
十二种活性化合物显著抑制了肠道收缩.
机制包括通道阻塞,氧化合成酶激活和其他途径.
化和4'-OH组增强了活性,而糖化一般降低了活性.

结论:

尾状黄蜂对IBS-D具有显著的治疗潜力,这归因于其多样化的黄化合物成分.
已识别的黄类药物通过多种药理途径发挥其作用,为传统使用提供了机制基础.
这些发现为开发用于IBS-D的基于黄类药物的新疗法提供了宝贵的见解.

关键词:

生物活性的黄酸盐.肠道收缩路径肠道收缩路径欧维亚尾状数据的茎.小肠机动性 ex vivo 小肠机动性化二黄的稳定性在化二黄中

更多相关视频

Gastrointestinal Motility Monitor GIMM

Gastrointestinal Motility Monitor GIMM

Published on: December 1, 2010

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines

Published on: January 27, 2016

相关概念视频

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

Drugs Affecting GI Tract Motility: Other Laxatives

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...

Gastrointestinal Motility Disorders

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...